ASTH Form 4: Insider Surrenders Shares; 176,946 Shares Remain
Rhea-AI Filing Summary
Basho Chandan, Astrana Health (ASTH) COO and CFO, reported a Form 4 disclosing a transaction on 09/05/2025 in which 1,694 shares of common stock were surrendered to cover tax withholding for vested restricted stock units at an effective price of $29.70 per share. After the surrender, the filing shows beneficial ownership of 176,946 shares.
The filing also details unvested restricted stock and restricted stock unit schedules: 7,214 shares vesting 4/14/2026; 30,404 shares vesting in two equal annual installments on 5/16/2026 and 5/16/2027; 23,404 RSUs vesting in six semi-annual installments beginning 10/02/2025; and 23,364 RSUs vesting in seven semi-annual installments beginning 03/05/2026. The transaction is coded F and represents a tax-withholding surrender, a routine insider action.
Positive
- Disclosure compliance: Form 4 filed, providing transparency on insider ownership changes
- Substantial remaining ownership: Reporting person retains 176,946 shares after the transaction
- Long-term alignment: Multiple unvested restricted stock and RSU tranches vesting through 2027 support retention incentives
Negative
- Minor reduction in issued shares due to surrender of 1,694 shares for tax withholding
- Potential dilution: Outstanding unvested awards will increase share count when they vest (schedules through 2027)
Insights
TL;DR: Routine share surrender to satisfy tax withholding; ownership largely intact with scheduled vesting over 2025–2027.
The reported F code transaction reflects surrender of 1,694 shares to cover taxes on vested RSUs at $29.70 per share. This is an administrative action rather than a sale for liquidity or diversification, leaving total beneficial ownership at 176,946 shares. The disclosed vesting schedule shows material incremental equity incentives through 2027, which aligns management compensation with future service and performance milestones. For investors, this is neutral in isolation but confirms ongoing equity retention by a senior officer.
TL;DR: Filing indicates standard insider tax-withholding and continued alignment via multi-year vesting schedules.
The Form 4 documents a standard withholding mechanism following RSU vesting; the use of surrendered shares (not open-market sales) suggests no immediate intent to materially reduce insider stake. The detailed vesting timetables for both restricted stock and RSUs demonstrate continued retention incentives. From a governance perspective, this supports alignment between executive and shareholder interests and is not a red flag for governance concerns.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,694 | $29.70 | $50K |
Footnotes (1)
- Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
